1,343
Views
5
CrossRef citations to date
0
Altmetric
Research Articles

Integrated docking and enhanced sampling-based selection of repurposing drugs for SARS-CoV-2 by targeting host dependent factors

ORCID Icon, , , &
Pages 9897-9908 | Received 18 Dec 2020, Accepted 24 May 2021, Published online: 22 Jun 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Lokpati Mishra & Tusar Bandyopadhyay. (2023) Unbinding of hACE2 and inhibitors from the receptor binding domain of SARS-CoV-2 spike protein. Journal of Biomolecular Structure and Dynamics 41:8, pages 3245-3264.
Read now

Articles from other publishers (4)

Yoshifumi Fukunishi, Junichi Higo & Kota Kasahara. (2022) Computer simulation of molecular recognition in biomolecular system: from in silico screening to generalized ensembles. Biophysical Reviews 14:6, pages 1423-1447.
Crossref
Kaifu Gao, Rui Wang, Jiahui Chen, Limei Cheng, Jaclyn Frishcosy, Yuta Huzumi, Yuchi Qiu, Tom Schluckbier, Xiaoqi Wei & Guo-Wei Wei. (2022) Methodology-Centered Review of Molecular Modeling, Simulation, and Prediction of SARS-CoV-2. Chemical Reviews 122:13, pages 11287-11368.
Crossref
Debabrata Pramanik, Aiswarya B. Pawar, Sudip Roy & Jayant Kumar Singh. (2022) Mechanistic insights of key host proteins and potential repurposed inhibitors regulating SARS ‐CoV ‐2 pathway . Journal of Computational Chemistry 43:18, pages 1237-1250.
Crossref
Hung-Teh Kao, Andrew Orry, Michael G. Palfreyman & Barbara Porton. (2022) Synergistic interactions of repurposed drugs that inhibit Nsp1, a major virulence factor for COVID-19. Scientific Reports 12:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.